Sol-Gel Technologies (SLGL) reported its Q2 2025 financial results before the market open
The company posted revenue of $17.26 million, significantly surpassing the estimated $2.9 million and marking a substantial increase from $5.43 million in the same quarter last year
Despite the strong revenue performance, the company’s earnings stood at $4.17, far above the expected loss of $0.07 and a notable improvement from $0.70 earnings in the year-ago quarter
Revenue soared by approximately 217% compared to estimates and increased roughly 218% compared to the same quarter last year
Earnings showed a remarkable turnaround, with the actual profit vastly exceeding both the estimates and last year’s figures
Earnings Insight
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/15/2025 | BMO | SLGL | Sol-Gel Technologies | Q2 2025 | EPS | -0.07 | 4.17 | 6,057.14 | 0.70 | 495.70 | |
| 05/23/2025 | BMO | SLGL | Sol-Gel Technologies | Q1 2025 | EPS | -0.12 | -3.20 | -2.00 | -0.23 | -1.00 | Healthcare / Biotechnology |
| 04/29/2025 | BMO | SLGL | Sol-Gel Technologies | Q4 2024 | EPS | -0.11 | -0.21 | -90.91 | -0.17 | -23.50 | Healthcare / Biotechnology |